{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:31:29Z","timestamp":1791657089151,"version":"4.3.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dermatomyositis (DM) is an acquired autoimmune disease that can cause damage to various organs, including the heart muscle. However, the mechanisms underlying myocardial injury in DM are not yet fully understood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we utilized publicly available datasets from the Gene Expression Omnibus (GEO) database to identify hub-genes that are enriched in the immune system process in DM and myocarditis. Weighted gene co-expression network analysis (WGCNA), differentially expressed genes (DEGs) analysis, protein\u2013protein interaction (PPI), and gene ontology (GO) analysis were employed to identify these hub-genes. We then used the CIBERSORT method to analyze immune cell infiltration in skeletal muscle specimens of DM and myocardium specimens of myocarditis respectively. Correlation analysis was performed to investigate the relationship between key genes and infiltrating immune cells. Finally, we predicted regulatory miRNAs of hub-genes through miRNet and validated their expression in online datasets and clinical samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Using integrated bioinformatics analysis, we identified 10 and 5 hub-genes that were enriched in the immune system process in the database of DM and myocarditis respectively. The subsequent intersections between hub-genes were IFIT3, OAS3, ISG15, and RSAD2. We found M2 macrophages increased in DM and myocarditis compared to the healthy control, associating with the expression of IFIT3, OAS3, ISG15, and RSAD2 in DM and myocarditis positively. Gene function enrichment analysis (GSEA) showed that IFIT3, OAS3, ISG15, and RSAD2 were mainly enriched in type I interferon (IFN) signaling pathway, cellular response to type I interferon, and response to type I interferon. Finally, we verified that the expression of miR-146a-5p was significantly higher in the DM with myocardial injury than those without myocardial injury (<jats:italic>p<\/jats:italic>\u2009=\u20090.0009).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings suggest that IFIT3, OAS3, ISG15, and RSAD2 may play crucial roles in the underlying mechanism of myocardial injury in DM. Serum miR-146a-5p could be a potential biomarker for myocardial injury in DM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03052-4","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T06:02:33Z","timestamp":1682661753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification of key biomarkers associated with immune cells infiltration for myocardial injury in dermatomyositis by integrated bioinformatics analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinsu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"issue":"2","key":"3052_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol. 2020;82(2):267\u201381.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3052_CR2","first-page":"256","volume":"153","author":"P Sena","year":"2018","unstructured":"Sena P, Gianatti A, Gambini D. Dermatomyositis: clinicopathological correlations. G Ital Dermatol Venereol. 2018;153(2):256\u201364.","journal-title":"G Ital Dermatol Venereol"},{"issue":"11","key":"3052_CR3","first-page":"686","volume":"35","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang GC, Ma L, Zu N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol. 2012;35(11):686\u201391.","journal-title":"Clin Cardiol"},{"issue":"8","key":"3052_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.12691\/ajmcr-6-8-3","volume":"6","author":"PT Kariyanna","year":"2018","unstructured":"Kariyanna PT, Jayarangaiah A, Mahmood A, Hare M, Taklalsingh N, McFarlane IM. Rapid progression of heart failure in a patient with idiopathic inflammatory myopathy. Am J Med Case Rep. 2018;6(8):157\u201360.","journal-title":"Am J Med Case Rep"},{"issue":"3","key":"3052_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/joim.13309","volume":"290","author":"A Yafasova","year":"2021","unstructured":"Yafasova A, Diederichsen LP, Schou M, Sun G, Torp-Pedersen C, Gislason GH, Fosbol EL, Kober L, Butt JH. Increased long-term risk of heart failure and other adverse cardiac outcomes in dermatomyositis and polymyositis: Insights from a nationwide cohort. J Intern Med. 2021;290(3):704\u201314.","journal-title":"J Intern Med"},{"issue":"10","key":"3052_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/art.1780221007","volume":"22","author":"CE Denbow","year":"1979","unstructured":"Denbow CE, Lie JT, Tancredi RG, Bunch TW. Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum. 1979;22(10):1088\u201392.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3052_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/0002-9149(82)90408-8","volume":"50","author":"HM Haupt","year":"1982","unstructured":"Haupt HM, Hutchins GM. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol. 1982;50(5):998\u20131006.","journal-title":"Am J Cardiol"},{"issue":"7","key":"3052_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/acr.22772","volume":"68","author":"LP Diederichsen","year":"2016","unstructured":"Diederichsen LP, Simonsen JA, Diederichsen AC, Hvidsten S, Hougaard M, Junker P, Sondergaard K, Lundberg IE, Tvede N, Sandgaard NC, et al. Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res (Hoboken). 2016;68(7):1012\u201320.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"3052_CR9","first-page":"313","volume":"39","author":"F Prisco","year":"2020","unstructured":"Prisco F, Papparella S, Paciello O. The correlation between cardiac and skeletal muscle pathology in animal models of idiopathic inflammatory myopathies. Acta Myol. 2020;39(4):313\u20139.","journal-title":"Acta Myol"},{"issue":"3","key":"3052_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nbt0308-303","volume":"26","author":"M Ringner","year":"2008","unstructured":"Ringner M. What is principal component analysis? Nat Biotechnol. 2008;26(3):303\u20134.","journal-title":"Nat Biotechnol"},{"key":"3052_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"3052_CR12","doi-asserted-by":"publisher","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","volume":"4","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"3052_CR13","doi-asserted-by":"publisher","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"7","key":"3052_CR14","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3052_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"3052_CR16","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","volume":"2","author":"K Ito","year":"2013","unstructured":"Ito K, Murphy D. Application of ggplot2 to Pharmacometric Graphics. CPT Pharmacometrics Syst Pharmacol. 2013;2:e79.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"6","key":"3052_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.chom.2015.11.002","volume":"18","author":"S Tripathi","year":"2015","unstructured":"Tripathi S, Pohl MO, Zhou Y, Rodriguez-Frandsen A, Wang G, Stein DA, Moulton HM, DeJesus P, Che J, Mulder LC, et al. Meta- and orthogonal integration of influenza \u201cOMICs\u201d data defines a role for UBR4 in virus budding. Cell Host Microbe. 2015;18(6):723\u201335.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"3052_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"15","key":"3052_CR19","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"3","key":"3052_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","volume":"32","author":"JA Vizcaino","year":"2014","unstructured":"Vizcaino JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Rios D, Dianes JA, Sun Z, Farrah T, Bandeira N, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32(3):223\u20136.","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"3052_CR21","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3052_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","volume":"31","author":"C von Mering","year":"2003","unstructured":"von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3052_CR23","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"Web Server issu","key":"3052_CR24","doi-asserted-by":"publisher","first-page":"W438","DOI":"10.1093\/nar\/gkn257","volume":"36","author":"CY Lin","year":"2008","unstructured":"Lin CY, Chin CH, Wu HH, Chen SH, Ho CW, Ko MT. Hubba: hub objects analyzer\u2013a framework of interactome hubs identification for network biology. Nucleic Acids Res. 2008;36(Web Server issue):W438-443.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3052_CR25","doi-asserted-by":"publisher","first-page":"W135","DOI":"10.1093\/nar\/gkw288","volume":"44","author":"Y Fan","year":"2016","unstructured":"Fan Y, Siklenka K, Arora SK, Ribeiro P, Kimmins S, Xia J. miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic Acids Res. 2016;44(W1):W135-141.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"3052_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"3052_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"2","key":"3052_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1081\/JCMR-200053623","volume":"7","author":"O Bondarenko","year":"2005","unstructured":"Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson. 2005;7(2):481\u20135.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"3052_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jmri.25945","volume":"48","author":"L Yu","year":"2018","unstructured":"Yu L, Sun J, Sun J, Li J, Dong Y, Zhou X, Greiser A, Han Y, Zhang Q, Xie Q, et al. Early detection of myocardial involvement by T1 mapping of cardiac MRI in idiopathic inflammatory myopathy. J Magn Reson Imaging. 2018;48(2):415\u201322.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"3052_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","volume":"18","author":"P Haaf","year":"2016","unstructured":"Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016;18(1):89.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"3052_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","volume":"41","author":"SM Sultan","year":"2002","unstructured":"Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford). 2002;41(1):22\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3052_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1536\/ihj.17-204","volume":"59","author":"F Chen","year":"2018","unstructured":"Chen F, Peng Y, Chen M. Diagnostic approach to cardiac involvement in idiopathic inflammatory myopathies. Int Heart J. 2018;59(2):256\u201362.","journal-title":"Int Heart J"},{"issue":"6","key":"3052_CR33","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/rheumatology\/keaa721","volume":"60","author":"M Qiu","year":"2021","unstructured":"Qiu M, Sun X, Qi X, Liu X, Zhang Y, Zhang N, Lu F, Liu W, Changjing F, Wang Q, et al. The diagnostic value of GDF-15 for myocardial involvement in idiopathic inflammatory myopathy. Rheumatology (Oxford). 2021;60(6):2826\u201333.","journal-title":"Rheumatology (Oxford)"},{"key":"3052_CR34","first-page":"8","volume":"2017","author":"T Sezin","year":"1992","unstructured":"Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig RJ. Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4(+) T cells. Front Immunol. 1992;2017:8.","journal-title":"Front Immunol"},{"issue":"1","key":"3052_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-019-1790-x","volume":"17","author":"R Zou","year":"2019","unstructured":"Zou R, Zhang D, Lv L, Shi W, Song Z, Yi B, Lai B, Chen Q, Yang S, Hua P. Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke. J Transl Med. 2019;17(1):45.","journal-title":"J Transl Med"},{"issue":"6","key":"3052_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/1567205017666200810164932","volume":"17","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Ding X, She Z, Bai X, Nie Z, Wang F, Wang F, Geng X. Exploring shared pathogenesis of Alzheimer\u2019s disease and type 2 diabetes mellitus via co-expression networks analysis. Curr Alzheimer Res. 2020;17(6):566\u201375.","journal-title":"Curr Alzheimer Res"},{"issue":"9250","key":"3052_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96\u2013100.","journal-title":"Lancet"},{"issue":"4","key":"3052_CR38","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3892\/mmr.2016.5703","volume":"14","author":"LY Chen","year":"2016","unstructured":"Chen LY, Cui ZL, Hua FC, Yang WJ, Bai Y, Lan FH. Bioinformatics analysis of gene expression profiles of dermatomyositis. Mol Med Rep. 2016;14(4):3785\u201390.","journal-title":"Mol Med Rep"},{"key":"3052_CR39","doi-asserted-by":"publisher","first-page":"102869","DOI":"10.1016\/j.jaut.2022.102869","volume":"132","author":"KZ Siddiqi","year":"2022","unstructured":"Siddiqi KZ, Zinglersen AH, Iversen KK, Rasmussen NS, Nielsen CT, Jacobsen S. A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus. J Autoimmun. 2022;132:102869.","journal-title":"J Autoimmun"},{"issue":"6","key":"3052_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/ar3531","volume":"13","author":"EC Baechler","year":"2011","unstructured":"Baechler EC, Bilgic H, Reed AM. Type I interferon pathway in adult and juvenile dermatomyositis. Arthritis Res Ther. 2011;13(6):249.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3052_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/art.40328","volume":"70","author":"C Gitiaux","year":"2018","unstructured":"Gitiaux C, Latroche C, Weiss-Gayet M, Rodero MP, Duffy D, Bader-Meunier B, Glorion C, Nusbaum P, Bodemer C, Mouchiroud G, et al. Myogenic progenitor cells exhibit type I interferon-driven proangiogenic properties and molecular signature during juvenile dermatomyositis. Arthritis Rheumatol. 2018;70(1):134\u201345.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"3052_CR42","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/brain\/awy105","volume":"141","author":"L Ladislau","year":"2018","unstructured":"Ladislau L, Suarez-Calvet X, Toquet S, Landon-Cardinal O, Amelin D, Depp M, Rodero MP, Hathazi D, Duffy D, Bondet V, et al. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. Brain. 2018;141(6):1609\u201321.","journal-title":"Brain"},{"issue":"6","key":"3052_CR43","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jid.2019.10.020","volume":"140","author":"C Cassius","year":"2020","unstructured":"Cassius C, Amode R, Delord M, Battistella M, Poirot J, How-Kit A, Lepelletier C, Jachiet M, de Masson A, Frumholtz L, et al. MDA5(+) dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with upregulation of IFN-kappa transcript. J Invest Dermatol. 2020;140(6):1276-1279 e1277.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3052_CR44","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaad.2020.05.051","volume":"84","author":"Y Kuriyama","year":"2021","unstructured":"Kuriyama Y, Shimizu A, Kanai S, Oikawa D, Tokunaga F, Tsukagoshi H, Ishikawa O. The synchronized gene expression of retrotransposons and type I interferon in dermatomyositis. J Am Acad Dermatol. 2021;84(4):1103\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3052_CR45","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41467-021-22312-y","volume":"12","author":"N Buang","year":"2021","unstructured":"Buang N, Tapeng L, Gray V, Sardini A, Whilding C, Lightstone L, Cairns TD, Pickering MC, Behmoaras J, Ling GS, et al. Type I interferons affect the metabolic fitness of CD8(+) T cells from patients with systemic lupus erythematosus. Nat Commun. 2021;12(1):1980.","journal-title":"Nat Commun"},{"issue":"3","key":"3052_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.41518","volume":"73","author":"KA Casey","year":"2021","unstructured":"Casey KA, Smith MA, Sinibaldi D, Seto NL, Playford MP, Wang X, Carlucci PM, Wang L, Illei G, Yu B, et al. Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus. Arthritis Rheumatol. 2021;73(3):459\u201371.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"3052_CR47","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10067-020-05568-5","volume":"40","author":"R Yin","year":"2021","unstructured":"Yin R, Wang G, Zhang L, Li T, Liu S. Dermatomyositis: immunological landscape, biomarkers, and potential candidate drugs. Clin Rheumatol. 2021;40(6):2301\u201310.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3052_CR48","first-page":"e142","volume":"170","author":"F Ragusa","year":"2019","unstructured":"Ragusa F. Dermatomyositis and MIG. Clin Ter. 2019;170(2):e142\u20137.","journal-title":"Clin Ter"},{"key":"3052_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fimmu.2020.00037","volume":"11","author":"T Jiang","year":"2020","unstructured":"Jiang T, Huang Y, Liu H, Xu Q, Gong Y, Chen Y, Hu X, Han Z, Gao M. Reduced miR-146a promotes REG3A expression and macrophage migration in polymyositis and dermatomyositis. Front Immunol. 2020;11:37.","journal-title":"Front Immunol"},{"issue":"6","key":"3052_CR50","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3899\/jrheum.141307","volume":"42","author":"QL Peng","year":"2015","unstructured":"Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC. Elevated serum levels of soluble CD163 in polymyositis and dermatomyositis: associated with macrophage infiltration in muscle tissue. J Rheumatol. 2015;42(6):979\u201387.","journal-title":"J Rheumatol"},{"issue":"8","key":"3052_CR51","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.ajpath.2019.04.009","volume":"189","author":"FJ Carrillo-Salinas","year":"2019","unstructured":"Carrillo-Salinas FJ, Ngwenyama N, Anastasiou M, Kaur K, Alcaide P. Heart inflammation: immune cell roles and roads to the heart. Am J Pathol. 2019;189(8):1482\u201394.","journal-title":"Am J Pathol"},{"issue":"1","key":"3052_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/cells10010051","volume":"10","author":"WP Lafuse","year":"2020","unstructured":"Lafuse WP, Wozniak DJ, Rajaram MVS. Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair. Cells. 2020;10(1):51.","journal-title":"Cells"},{"issue":"2","key":"3052_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jjcc.2020.08.004","volume":"77","author":"JI Kawada","year":"2021","unstructured":"Kawada JI, Takeuchi S, Imai H, Okumura T, Horiba K, Suzuki T, Torii Y, Yasuda K, Imanaka-Yoshida K, Ito Y. Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT. J Cardiol. 2021;77(2):174\u20138.","journal-title":"J Cardiol"},{"key":"3052_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514.","journal-title":"Front Immunol"},{"issue":"2","key":"3052_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1084\/jem.20180722","volume":"216","author":"A Anzai","year":"2019","unstructured":"Anzai A, Mindur JE, Halle L, Sano S, Choi JL, He S, McAlpine CS, Chan CT, Kahles F, Valet C, et al. Self-reactive CD4(+) IL-3(+) T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis. J Exp Med. 2019;216(2):369\u201383.","journal-title":"J Exp Med"},{"issue":"5","key":"3052_CR56","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.immuni.2017.10.011","volume":"47","author":"X Clemente-Casares","year":"2017","unstructured":"Clemente-Casares X, Hosseinzadeh S, Barbu I, Dick SA, Macklin JA, Wang Y, Momen A, Kantores C, Aronoff L, Farno M, et al. A CD103(+) conventional dendritic cell surveillance system prevents development of overt heart failure during subclinical viral myocarditis. Immunity. 2017;47(5):974-989 e978.","journal-title":"Immunity"},{"issue":"1","key":"3052_CR57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.celrep.2019.06.007","volume":"28","author":"X Hou","year":"2019","unstructured":"Hou X, Chen G, Bracamonte-Baran W, Choi HS, Diny NL, Sung J, Hughes D, Won T, Wood MK, Talor MV, et al. The cardiac microenvironment instructs divergent monocyte fates and functions in myocarditis. Cell Rep. 2019;28(1):172-189 e177.","journal-title":"Cell Rep"},{"key":"3052_CR58","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3389\/fimmu.2019.01642","volume":"10","author":"AA Wolf","year":"2019","unstructured":"Wolf AA, Yanez A, Barman PK, Goodridge HS. The ontogeny of monocyte subsets. Front Immunol. 2019;10:1642.","journal-title":"Front Immunol"},{"issue":"8","key":"3052_CR59","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"G Bajpai","year":"2018","unstructured":"Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, Epelman S, Kreisel D, Liu Y, Itoh A, et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med. 2018;24(8):1234\u201345.","journal-title":"Nat Med"},{"issue":"23","key":"3052_CR60","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.jacc.2016.09.945","volume":"68","author":"T Barwari","year":"2016","unstructured":"Barwari T, Joshi A, Mayr M. MicroRNAs in cardiovascular disease. J Am Coll Cardiol. 2016;68(23):2577\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"3052_CR61","first-page":"iii50","volume":"67 Suppl 3","author":"FJ Sheedy","year":"2008","unstructured":"Sheedy FJ, O\u2019Neill LA. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis. 2008;67 Suppl 3:iii50-55.","journal-title":"Ann Rheum Dis"},{"issue":"33","key":"3052_CR62","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3052_CR63","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.2337\/db11-0478","volume":"60","author":"B Feng","year":"2011","unstructured":"Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S. miR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes. 2011;60(11):2975\u201384.","journal-title":"Diabetes"},{"issue":"9","key":"3052_CR64","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4049\/immunohorizons.2000075","volume":"4","author":"BK Shimada","year":"2020","unstructured":"Shimada BK, Yang Y, Zhu J, Wang S, Suen A, Kronstadt SM, Jeyaram A, Jay SM, Zou L, Chao W. Extracellular miR-146a-5p induces cardiac innate immune response and cardiomyocyte dysfunction. Immunohorizons. 2020;4(9):561\u201372.","journal-title":"Immunohorizons"},{"key":"3052_CR65","doi-asserted-by":"publisher","first-page":"6581217","DOI":"10.1155\/2019\/6581217","volume":"2019","author":"G Lin","year":"2019","unstructured":"Lin G, Huang J, Chen Q, Chen L, Feng D, Zhang S, Huang X, Huang Y, Lin Q. miR-146a-5p mediates intermittent hypoxia-induced injury in H9c2 cells by targeting XIAP. Oxid Med Cell Longev. 2019;2019:6581217.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"3052_CR66","doi-asserted-by":"publisher","first-page":"9274","DOI":"10.1002\/jcp.27607","volume":"234","author":"L Shu","year":"2019","unstructured":"Shu L, Zhang W, Huang G, Huang C, Zhu X, Su G, Xu J. Troxerutin attenuates myocardial cell apoptosis following myocardial ischemia-reperfusion injury through inhibition of miR-146a-5p expression. J Cell Physiol. 2019;234(6):9274\u201382.","journal-title":"J Cell Physiol"},{"key":"3052_CR67","doi-asserted-by":"crossref","unstructured":"Dong M, Chen D, Zhu Y, Yang S, Kumar S, Zhang R, Zhou Y, Yang Z, Zheng N, Zhu T, et al. Impaired regulation of MMP2\/16-MLCK3 by miR-146a-5p increased susceptibility to myocardial ischemic injury in aging mice. Cardiovasc Res. 2022:cvac104.","DOI":"10.1093\/cvr\/cvac104"},{"issue":"6","key":"3052_CR68","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1161\/CIRCRESAHA.118.312751","volume":"123","author":"JG Oh","year":"2018","unstructured":"Oh JG, Watanabe S, Lee A, Gorski PA, Lee P, Jeong D, Liang L, Liang Y, Baccarini A, Sahoo S, et al. miR-146a suppresses SUMO1 expression and induces cardiac dysfunction in maladaptive hypertrophy. Circ Res. 2018;123(6):673\u201385.","journal-title":"Circ Res"},{"issue":"3","key":"3052_CR69","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/cvr\/cvs356","volume":"97","author":"X Wang","year":"2013","unstructured":"Wang X, Ha T, Liu L, Zou J, Zhang X, Kalbfleisch J, Gao X, Williams D, Li C. Increased expression of microRNA-146a decreases myocardial ischaemia\/reperfusion injury. Cardiovasc Res. 2013;97(3):432\u201342.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"3052_CR70","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.310529","volume":"121","author":"HS Cheng","year":"2017","unstructured":"Cheng HS, Besla R, Li A, Chen Z, Shikatani EA, Nazari-Jahantigh M, Hammoutene A, Nguyen MA, Geoffrion M, Cai L, et al. Paradoxical suppression of atherosclerosis in the absence of microRNA-146a. Circ Res. 2017;121(4):354\u201367.","journal-title":"Circ Res"},{"issue":"7","key":"3052_CR71","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/biom11070962","volume":"11","author":"AV Zhelankin","year":"2021","unstructured":"Zhelankin AV, Stonogina DA, Vasiliev SV, Babalyan KA, Sharova EI, Doludin YV, Shchekochikhin DY, Generozov EV, Akselrod AS. Circulating extracellular miRNA analysis in patients with stable CAD and acute coronary syndromes. Biomolecules. 2021;11(7):962.","journal-title":"Biomolecules"},{"key":"3052_CR72","doi-asserted-by":"publisher","first-page":"103338","DOI":"10.1016\/j.ebiom.2021.103338","volume":"66","author":"M Lozano-Prieto","year":"2021","unstructured":"Lozano-Prieto M, Adlam D, Garcia-Guimaraes M, Sanz-Garcia A, Vera-Tome P, Rivero F, Cuesta J, Bastante T, Baranowska-Clarke AA, Vara A, et al. Differential miRNAs in acute spontaneous coronary artery dissection: pathophysiological insights from a potential biomarker. EBioMedicine. 2021;66:103338.","journal-title":"EBioMedicine"},{"key":"3052_CR73","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12967-015-0672-0","volume":"13","author":"L Fang","year":"2015","unstructured":"Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015;13:314.","journal-title":"J Transl Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03052-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T07:07:02Z","timestamp":1682665622000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03052-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3052"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03052-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committee of The First Affiliated Hospital of Nanjing Medical University. Ethical approval was obtained for our single-center cross-sectional study, and the need to obtain informed consent was waived (2020-SR-228).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}